ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,329Medicare Part D Prescriptions Filled, Including Refills

Rank: 83 out of 223

$319K Total Retail Price of All Prescriptions

Rank: 126 out of 223

351 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
8% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Utah
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 351 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

14% of this provider’s 351 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

3% of this provider’s 6,447 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$44 was the average price of a prescription from this provider, compared to $62 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Utah
SIMVASTATIN 394 343 1 1
LEVOTHYROXINE SODIUM 311 289 2 2
LISINOPRIL 285 282 3 4
OMEPRAZOLE 263 224 4 3
ZOLPIDEM TARTRATE 234 201 5 8
METFORMIN HCL 219 211 6 7
TRAZODONE HCL 193 134 7 22
AMLODIPINE BESYLATE 178 174 8 6
HYDROCODONE-ACETAMINOPHEN 163 120 S3 9 5
CITALOPRAM HBR 152 139 10 16
FLUOXETINE HCL 148 117 11 24
GABAPENTIN 145 124 12 10
HYDROCHLOROTHIAZIDE 141 132 13 13
POTASSIUM CHLORIDE 120 108 14 12
FUROSEMIDE 117 115 15 9
LOVASTATIN 115 106 16 51
GLYBURIDE 101 96 R 17 71
TRAMADOL HCL 99 94 18 18
ATENOLOL 98 88 19 32
AZITHROMYCIN 97 79 20 44
WARFARIN SODIUM 94 83 21 11
MELOXICAM 93 82 22 33
ATORVASTATIN CALCIUM 87 87 23 17
LOSARTAN POTASSIUM 87 80 23 14
METOPROLOL SUCCINATE 82 66 25 20
METOPROLOL TARTRATE 78 78 26 25
NAPROXEN 75 61 27 80
FLUTICASONE PROPIONATE 74 62 28 27
LOSARTAN-HYDROCHLOROTHIAZIDE 69 61 29 31
LEVOXYL 69 58 29 78
METHADONE HCL 65 45 S2 31 114
CELEBREX 64 64 32 42
TERAZOSIN HCL 63 63 33 125
TAMSULOSIN HCL 63 60 33 26
CARISOPRODOL 61 46 R 35 63
CRESTOR 59 59 36 37
BUPROPION XL 58 36 37 117
SYNTHROID 57 55 38 35
CIPROFLOXACIN HCL 55 48 39 53
GEMFIBROZIL 53 45 40 137
ALLOPURINOL 51 50 41 28
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 5, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.